Bridgefront Capital’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,626
| Closed | -$157K | – | 352 |
|
|
2021
Q4 | $157K | Buy |
1,626
+230
| +16% | +$22.2K | 0.15% | 261 |
|
|
2021
Q3 | $122K | Buy |
+1,396
| New | +$122K | 0.13% | 265 |
|
|
2021
Q2 | – | Sell |
-2,492
| Closed | -$393K | – | 763 |
|
|
2021
Q1 | $393K | Buy |
2,492
+1,492
| +149% | +$235K | 0.12% | 334 |
|
|
2020
Q4 | $232K | Buy |
+1,000
| New | +$232K | 0.08% | 465 |
|